Cequa Ophthalmic Solution (0.25ml Each)
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Ciclosporin (0.09% w/v)
Overview Cequa Ophthalmic Solution (0.25ml Each)
Cequa (0.25ml single-dose units) eye drops treat dry eyes by reducing inflammation, thus boosting tear production. This lubrication alleviates dryness discomfort. Do not use if the container seal is compromised. Always wash hands before application and shake the bottle thoroughly. Remove contact lenses; reinsert after at least 15 minutes. Improvement may take weeks; continue as directed. Common side effects include blurry vision and eye burning. Avoid driving with blurred vision; this usually resolves quickly, but consult your doctor if persistent. Interactions with other medications are unlikely, but inform your doctor of prior similar medication use and allergies. Pregnant or breastfeeding individuals should not use Cequa.
Uses of Cequa Ophthalmic Solution (0.25ml Each)
Ocular dryness
Major Benefits of Cequa Ophthalmic Solution (0.25ml Each):
Apply this medication externally only. Administer as directed by your physician, following the prescribed dosage and schedule. Consult the product label for application instructions prior to use. Position the dropper near the eye, avoiding contact. Carefully dispense the medication into the lower conjunctival sac. Remove any excess solution.
Common Side effects of Cequa Ophthalmic Solution (0.25ml Each):
- Blurred vision
- Burning sensation in eye
- Headache
- High blood pressure
- Renal dysfunction
- Tremors
- Increased glucose level in blood
- Paresthesia (tingling or pricking sensation)
- Acne
- Decreased white blood cell count
- Increased levels of blood fat
- Decreased appetite
- Increased uric acid level in blood
- Electrolyte imbalance
- Convulsion
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Gastrointestinal disturbance
- Gingival hyperplasia
- Stomach ulcer
- Abnormal liver function
- Excessive hair growth on face
- Hypertrichosis (excessive hair growth)
- Muscle cramp
- Muscle pain
- Fever
- Fatigue
How to use Cequa Ophthalmic Solution (0.25ml Each):
Apply this medication solely to the outer surface of the body. Administer as directed by your physician, adhering to the prescribed dosage and treatment schedule. Consult the product label for detailed application instructions prior to use. Position the dropper near the eye, avoiding contact, then carefully dispense the medication into the lower conjunctival sac. Remove any excess solution.
How Cequa Ophthalmic Solution (0.25ml Each) works:
Cequa (0.25ml single-use vials) is an immunosuppressive eye drop that stimulates tear formation in patients with persistent dry eye. Its mechanism involves reducing ocular inflammation, thereby promoting tear production and alleviating dryness and discomfort.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
The use of Cequa Ophthalmic Solution (0.25ml units) during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before using this medication.
Breast feedingUNSAFE
The use of Cequa Ophthalmic Solution (0.25ml units) is contraindicated while breastfeeding due to potential infant toxicity.
DrivingCONSULT YOUR DOCTOR
Cequa Ophthalmic Solution (0.25ml per unit) may or may not affect driving ability. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Cequa Ophthalmic Solution (0.25ml Each) :
Should you forget a dose of Cequa Ophthalmic Solution (0.25ml per single-use container), administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cequa Ophthalmic Solution (0.25ml Each)
| Label | Value |
|---|---|
| Chemical Type | Cyclosporine Analog |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Behavioral Class | Calcineurin inhibitor immunosuppressants |





